Anti-FGF23 (Burosumab) in Adult Patients With XLH

Clinical trial NCT04695860 · COMPLETED

Trial details

NCT number: NCT04695860
Sponsor: Wuerzburg University Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

X-linked Hypophosphatemia

Start date: 2021-01-07
Primary completion: 2023-03-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.